Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
Author: Beverly Thomassian, RN, MPH, CDCES, BC-ADM CEO: DiabetesEd Services The landscape of metabolic monitoring has fundamentally shifted; the U.S. FDA authorizes the first Continuous Glucose-Ketone Monitor. The Libre Duo … Continue reading A New Paradigm in Diabetes Care: FDA Authorizes the World’s First Continuous Glucose-Ketone Monitor
Jordan is a 52-year-old person living with type 2 diabetes whose provider recently added a second daily medication after their A1C rose from 7.6% to 9.1%. Jordan works alternating shifts … Continue reading Test Your Knowledge Tuesday | Which response BEST supports sustainable medication-taking?
I had such a wonderful experience at the ADCES Conference in Columbus, Ohio! One of the greatest highlights was receiving dozens of hugs from colleagues who shared their joy of … Continue reading September 2026 e-News | Gastroparesis & Continuous Ketone Sensor
For last week’s practice question, we quizzed participants on which response BEST reflects PERMA framework. 77% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading What’s The Best Answer Thursday | Which response Best reflects a PERMA framework?
Author: Evgeniya Evans, MAPP, RDN, LDN, CDCES Diabetes care often asks people to add more to their busy daily schedules: more decisions, more data, more appointments, more routines. But what … Continue reading Stop Prescribing Lifestyle Change. Start Co-Designing for Flourishing.
A 62?year?old woman with type 2 diabetes is being followed in a value?based care program. She uses a continuous glucose monitor (CGM) that provides detailed glucose data, which she electronically … Continue reading Test Your Knowledge Tuesday | A1C unavailable, but GMI is 7.2%. How can glycemic control be documented?
For last week’s practice question, we quizzed participants on unpredictable glucose patters with bloating and nausea. 76% of respondents chose the best answer. We want to clarify and share this … Continue reading What’s the Best Answer Thursday | Unpredictable glucose patterns with bloating and nausea. Potential contributor?
Artificial intelligence (AI) is transforming diabetes prevention, monitoring, and management. As clinical care tasks and data grow exponentially, providers and individuals living with or at risk for diabetes seek ways … Continue reading Tools You Can Use: How Artificial Intelligence is Transforming Diabetes Care